Eli Lilly and Co banner

Eli Lilly and Co
SIX:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
SIX:LLY
Watchlist
Price: 945 CHF -2.58% Market Closed
Market Cap: CHf892.9B

Wall St Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 894.77 CHF with a low forecast of 621.23 CHF and a high forecast of 1 139.7 CHF.

Lowest Forecast
Price Target
621.23 CHF
34% Downside
Average Forecast
Price Target
894.77 CHF
5% Downside
Highest Forecast
Price Target
1 139.7 CHF
21% Upside
Eli Lilly and Co Competitors:
Price Targets
BTDR
Bitdeer Technologies Group
92% Upside
SPH
Suburban Propane Partners LP
-3% Downside
CPNREIT
CPN Retail Growth Leasehold REIT
-4% Downside

Revenue
Forecast

8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.

Gross Profit
Forecast

9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 12%.

Operating Income
Forecast

15% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
15% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
13% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.

Net Income
Forecast

13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LLY's stock price target?
Price Target
894.77 CHF

According to Wall Street analysts, the average 1-year price target for LLY is 894.77 CHF with a low forecast of 621.23 CHF and a high forecast of 1 139.7 CHF.

What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.

What is the Gross Profit forecast for Eli Lilly and Co?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.

What is the Pre-Tax Income forecast for Eli Lilly and Co?
Projected CAGR
31%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.

What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett